Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$2.9 million.

  • Palisade Bio's Net Income towards Common Stockholders rose 1775.16% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 2094.44%. This contributed to the annual value of -$14.9 million for FY2024, which is 1364.92% down from last year.
  • Per Palisade Bio's latest filing, its Net Income towards Common Stockholders stood at -$2.9 million for Q3 2025, which was up 1775.16% from -$2.8 million recorded in Q2 2025.
  • Over the past 5 years, Palisade Bio's Net Income towards Common Stockholders peaked at $5.1 million during Q3 2021, and registered a low of -$31.7 million during Q2 2021.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$3.4 million (2023), whereas its average is -$4.4 million.
  • The largest annual percentage gain for Palisade Bio's Net Income towards Common Stockholders in the last 5 years was 37775.37% (2021), contrasted with its biggest fall of 161507.29% (2021).
  • Palisade Bio's Net Income towards Common Stockholders (Quarter) stood at $5.1 million in 2021, then tumbled by 175.23% to -$3.9 million in 2022, then grew by 18.0% to -$3.2 million in 2023, then dropped by 7.19% to -$3.4 million in 2024, then grew by 15.27% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q3 2025, -$2.8 million for Q2 2025, and -$2.2 million during Q1 2025.